• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Availity, Concert Partner to Digitize and Automate Prior Authorization for Genetic Testing

by Syed Hamza Sohail 01/13/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

–       Availity®, the nation’s leading real-time health information network, and Concert®, the leading provider of clinical content and payment accuracy solutions for advanced diagnostics, have partnered to digitize and automate the prior authorization and payment processes for genetic tests.

–       Together the companies will enable more consistent, transparent, and instantaneous prior authorizations, reducing administrative burden in the delivery of precision medicine.    

Availity and Concert Collaborate to Streamline Genetic Testing Authorizations and Billing

Availity is transforming healthcare experiences by facilitating seamless exchanges of clinical, administrative, and financial information within established workflows. As the largest real-time health information network in the U.S., Availity connects over 95% of payers, 3 million providers, and 2,000 trading partners. Through its robust, cloud-first technology platform, Availity drives efficiency, security, and innovation using AI, data-driven insights, and a diversified product portfolio, establishing itself as a leader in the future of healthcare interoperability.

Addressing the Challenges of Genetic Testing

Advancements in genetic diagnostics and therapies allow for more personalized patient care, yet the complexity and cost of administering genetic tests remain a significant challenge. These tests often require prior authorization, which can overwhelm Utilization Management (UM) teams with rapidly evolving clinical guidelines, state-level biomarker regulations, and complex billing codes—especially for prenatal, oncology, and pharmacogenetic tests. The intricacy of these claims often leads to delays, denials, and manual reviews, causing confusion and frustration for patients, providers, and health plans.

Transforming Authorization with Concert and Availity Integration

To tackle these issues, Availity is integrating Concert’s clinical criteria, coding standards, and the Concert GTU® test identifier into its End-to-End Authorization solution. This collaboration will automate prior authorization processes, replacing manual, error-prone workflows with seamless, real-time authorization recommendations within existing health plan and provider systems. The expected benefits include:

   •       For Providers: Greater consistency and transparency in authorizations, with many rendered instantly.

   •       For Health Plans: A streamlined prior authorization process, clear knowledge of services rendered, and reduced burden on medical directors for complex reviews.

   •       For Patients: Reduced delays and uncertainty when genetic tests are ordered, with fewer surprise bills following testing.

A Vision for Instant Reimbursement

Rob Metcalf, CEO of Concert, shared, “At Concert, we envision a day when laboratory test reimbursement is determined instantly at the point of patient care. Concert’s flexible data platform integrates seamlessly with Availity’s network, enabling efficient, evidence-based precision health.”

This partnership marks a significant step toward improving the efficiency and accuracy of genetic testing authorizations, offering more consistent and timely healthcare experiences for all parties involved.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |